FDA says ivermectin doesn’t work against COVID-19 but studies show it does!

WASHINGTON (PNN) - December 8, 2022 - The Fascist Police States of Amerika (FPSA) Food and Drug Administration (FDA) says a drug called ivermectin does not work against COVID-19, but links to studies that show it does.

The FDA’s website states, “Currently available data do not show ivermectin is effective against COVID-19.”

But half of the studies to which the FDA points support using ivermectin against COVID-19.

The papers cut against the drug agency’s repeated exhortations for people not to take ivermectin for COVID-19. In Twitter posts, public statements, and emails, FDA officials have repeatedly warned against ivermectin. Some of those statements triggered a lawsuit from doctors who say the agency’s role is to approve drugs, not to issue recommendations. The lawsuit was dismissed this week.

Dr. Pierre Kory, who frequently prescribes ivermectin for COVID-19 and co-authored a meta-analysis that concluded the drug is effective against the illness, said that the government’s position on ivermectin “is one of the most glaring examples of the corruption of modern evidence-based medicine.”

“There’s one message they want everyone to understand; and that message is that ivermectin doesn’t work,” Kory said. “That’s not a scientific conclusion, that’s theirs. That’s their perverted and distorted interpretation of the data.”

The FDA’s media office did not respond to a request for comment.

Dr. Janet Woodcock, a top official at the agency who was its commissioner from January 2021 to February 2022, said via email that “ivermectin has been shown to be ineffective against COVID in large, randomized trials.”

The FDA’s website points to a FPSA National Library of Medicine database of studies analyzing ivermectin against COVID-19. There are 88 studies listed in the database.

Out of studies that are listed, have been completed, and have results reported, half show or indicate ivermectin effectively combats or prevents COVID-19.

They include papers reporting on results from randomized, controlled trials, which are often offered as the highest level of evidence by FPSA government officials. Such trials feature a group that receives a placebo and a group that receives the drug, randomization into groups, and blinding, or shielding operators and/or patients from the knowledge of which participants are receiving ivermectin.

Among the papers is a randomized, blinded, controlled trial that found people who received ivermectin and doxycycline, an antibiotic, recovered faster from COVID-19 than those who received a placebo.

Bangladeshi researchers reported the results from the trial of 363 participants on May 13, 2021, in the Journal of International Medical Research.

“Patients with mild-to-moderate COVID-19 infection treated with ivermectin plus doxycycline recovered earlier, were less likely to progress to more serious disease, and were more likely to be COVID-19 negative by RT-PCR on day 14,” they said. PCR has been used to test for COVID-19.

Another paper, published on July 7, 2022, in the International Journal of Infectious Diseases, found that ivermectin decreased the level of COVID-19 and its viability. Israeli researchers in the randomized, controlled, open label trial compared 47 patients who received ivermectin against 42 who received placebos and said that “ivermectin significantly reduced the time of viral shedding and affected viral viability when initiated in the first week after evidence of infection.”

“There were lower viral loads and less viable cultures in the ivermectin group, which shows its anti-SARS-CoV-2 activity,” the researchers said. SARS-CoV-2 is a name for the virus that causes COVID-19.

A third paper concluded that a regimen of ivermectin and carrageenan works as a prophylaxis, or preventative medicine. Argentinian researchers found in the observational trial involving 229 health care workers that ivermectin helped prevent COVID-19 infection. A follow-up study involving nearly 1,200 workers confirmed the results. Both sets were reported in the Journal of Clinical and Biomedical Investigation on November 17, 2020.

Ivermectin “could have saved so many lives,” said Héctor Carvallo, one of the researchers via email, adding that “it’s been a crime against mankind to prevent its prescription.”

Some other studies, including the largest ones, either found indications that ivermectin works against COVID-19 but did not achieve statistical significance, or found no evidence that ivermectin is effective.

In another trial that reported little difference between the treatment and control groups, the treatment group received ivermectin days after starting to show symptoms.

Ivermectin works best when applied within 24 hours of symptom manifestation, according to a mega regression of ivermectin studies performed by an unnamed group of researchers.

“They literally try to treat as late into the disease as they can, for as short a duration as they can, at the lowest dose that they can; and they also try to find as healthy and mild patients as you can,” Kory said.

“Yet, when they conduct those kinds of trials, it’s on the front page of a high-impact journal and the conclusion states, ‘this shows there’s no role for ivermectin in treatments.’ Absolutely absurd; and so it’s really just corruption of these trials.”